Binding site plasticity in viral PPxY Late domain recognition by the third WW domain of human NEDD4
Metadatos
Mostrar el registro completo del ítemEditorial
Springer Nature
Fecha
2019Referencia bibliográfica
Iglesias-Bexiga, M., Palencia, A., Corbi-Verge, C., Martin-Malpartida, P., Blanco, F. J., Macias, M. J., ... & Luque, I. (2019). Binding site plasticity in viral PPxY Late domain recognition by the third WW domain of human NEDD4. Scientific reports, 9(1), 1-17.
Patrocinador
This research has been financed by grants BIO2009-13261-C02, BIO2012-39922-CO2 and BIO2016-78746-C2-1-R from the Spanish Ministry of Education and Science (I.L.) including AEI/FEDER EU funds, by CTQ2017-83810-R grant (F.J.B) and by BFU2014-53787-P, the IRB Barcelona and the BBVA Foundation (M.J.M).Resumen
The recognition of PPxY viral Late domains by the third WW domain of the HECT-E3 ubiquitin ligase
NEDD4 (hNEDD4-WW3) is essential for the completion of the budding process of numerous enveloped
viruses, including Ebola, Marburg, HTLV1 or Rabies. hNEDD4-WW3 has been validated as a promising
target for the development of novel host-oriented broad spectrum antivirals. Nonetheless, finding
inhibitors with good properties as therapeutic agents remains a challenge since the key determinants
of binding affinity and specificity are still poorly understood. We present here a detailed structural
and thermodynamic study of the interactions of hNEDD4-WW3 with viral Late domains combining
isothermal titration calorimetry, NMR structural determination and molecular dynamics simulations.
Structural and energetic differences in Late domain recognition reveal a highly plastic hNEDD4-WW3
binding site that can accommodate PPxY-containing ligands with varying orientations. These
orientations are mostly determined by specific conformations adopted by residues I859 and T866.
Our results suggest a conformational selection mechanism, extensive to other WW domains, and
highlight the functional relevance of hNEDD4-WW3 domain conformational flexibility at the binding
interface, which emerges as a key element to consider in the search for potent and selective inhibitors of
therapeutic interest.